An elephant in the glasshouse? Trade-offs between acceleration and transformation in COVID-19 vaccine innovation policies
Open Access
- 24 May 2023
- journal article
- research article
- Published by Elsevier in Environmental Innovation and Societal Transitions
- Vol. 48, 100736
Abstract
No abstract availableKeywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VI.Veni.201S.044)
This publication has 72 references indexed in Scilit:
- Risk in Vaccine Research and Development QuantifiedPLOS ONE, 2013
- Legitimizing research, technology and innovation policies for transformative changeResearch Policy, 2012
- Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1PLOS Medicine, 2010
- Analyzing the functional dynamics of technological innovation systems: A scheme of analysisResearch Policy, 2008
- Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a reviewBMC Public Health, 2007
- Functions of innovation systems: A new approach for analysing technological changeTechnological Forecasting and Social Change, 2007
- Imagining sustainability: the added value of transition scenarios in transition managementForesight, 2006
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005
- Processes and patterns in transitions and system innovations: Refining the co-evolutionary multi-level perspectiveTechnological Forecasting and Social Change, 2005
- Technological transitions as evolutionary reconfiguration processes: a multi-level perspective and a case-studyResearch Policy, 2002